ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ALLK Allakos Inc

1.06
0.05 (4.95%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Allakos Inc ALLK 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.05 4.95% 1.06 08:48:39
개장가 저가 고가 종가 전일 종가
1.03 0.9807 1.03 1.02 1.01
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/03/202405:02GLOBEAllakos Provides Business Update and Reports Fourth Quarter..
07/03/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:22EDGAR2Form 144 - Report of proposed sale of securities
05/03/202407:52EDGAR2Form 144 - Report of proposed sale of securities
26/02/202421:05EDGAR2Form 8-K - Current report
26/02/202421:02GLOBEAllakos Presents Preclinical Data Highlighting Inhibition of..
22/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202409:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/02/202406:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202422:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/02/202421:07EDGAR2Form 8-K - Current report
12/02/202421:02GLOBEAllakos Announces Publication Highlighting AK006 Mast Cell..
03/02/202406:05EDGAR2Form 8-K - Current report
03/02/202402:31EDGAR2Form SC 13D/A - General statement of acquisition of..
17/01/202407:00EDGAR2Form 8-K - Current report
16/01/202421:02GLOBEAllakos Announces a Restructuring to Focus on Development of..
16/01/202421:00GLOBEAllakos Announces Phase 2 Lirentelimab Trials in Atopic..
06/01/202406:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202305:49EDGAR2Form 144 - Report of proposed sale of securities
05/12/202305:31EDGAR2Form 144 - Report of proposed sale of securities
05/12/202305:21EDGAR2Form 144 - Report of proposed sale of securities
27/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202307:01EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:10EDGAR2Form 8-K - Current report
14/11/202306:02GLOBEAllakos Provides Business Update and Reports Third Quarter..
08/09/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/09/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/09/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202305:06EDGAR2Form 144 - Report of proposed sale of securities
06/09/202304:57EDGAR2Form 144 - Report of proposed sale of securities
06/09/202304:52EDGAR2Form 144 - Report of proposed sale of securities
31/08/202306:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202305:05EDGAR2Form 8-K - Current report
31/08/202305:05GLOBEAllakos Appoints Neil Graham to its Board of Directors
22/08/202305:02EDGAR2Form 8-K - Current report
10/08/202305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:08EDGAR2Form 8-K - Current report
10/08/202305:02GLOBEAllakos Provides Business Update and Reports Second Quarter..
04/08/202307:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202307:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/08/202305:05GLOBEAllakos Appoints Rand Sutherland and Dolca Thomas to its..
03/08/202305:03EDGAR2Form 8-K - Current report
12/06/202320:02GLOBEAllakos Presents Preclinical Data at EAACI Hybrid Congress..

최근 히스토리

Delayed Upgrade Clock